Tetanus: Pathogenesis, Clinical Features, and Prevention

Causative agent: Clostridium tetani, a Gram-positive, spore-forming, obligate anaerobe ubiquitous in soil, dust, and animal feces.

Pathogenesis

  1. Entry: Spores introduced through contaminated wounds (punctures, burns, crush injuries, umbilical stump, injection drug use).
  2. Germination: In anaerobic tissue (necrotic, devitalized), spores → vegetative bacilli.
  3. Toxin production: Tetanospasmin (150 kDa neurotoxin) released; travels retrograde via motor axons or hematogenously to CNS.
  4. Mechanism: Tetanospasmin cleaves synaptobrevin (VAMP), blocking inhibitory neurotransmitter (GABA, glycine) release from spinal/brainstem interneurons.
  5. Result: Unopposed motor neuron excitation → generalized rigidity, painful spasms, autonomic instability.

Clinical Forms

  • Generalized (80%): Trismus (lockjaw), risus sardonicus, opisthotonus, spasms triggered by stimuli.
  • Localized: Rigidity/spasms near wound; may progress to generalized.
  • Cephalic: Cranial nerve palsies after head/face wounds.
  • Neonatal: Umbilical stump infection in unimmunized mothers; high mortality.

Prevention

  • Primary immunization: DTaP (pediatric) / Tdap (adolescent/adult) – 3-dose primary series + boosters every 10 years.
  • Wound management: Clean, debride, assess immunization status. Give Tdap/Td booster if >5 years since last dose (or >10 years for clean minor wounds). Tetanus immune globulin (TIG) for high-risk wounds with incomplete/unknown vaccination.

Tetanus is vaccine-preventable; global neonatal tetanus elimination efforts have reduced mortality dramatically, but sporadic cases persist in under-immunized populations.

Viral Infections - Related Articles